Skip to main content
. 2018 Oct 31;40(7):980–988. doi: 10.1038/s41401-018-0176-6

Fig. 4.

Fig. 4

Proposed metabolic pathways of pyrotinib in humans. (), percentage of metabolite in feces accounting for the dose administered (N.D., not detected by radiochromatography; asterisk M2 and M6-5 were coeluted by HPLC)